Strides Pharma trades 2% up after USFDA nod for drug to reduce heart issues
Shares of Strides Pharma Sciences rose 2% in early trading on September 25 after the company’s subsidiary received approval from the United States Food and Drug Administration (USFDA) for its treatment drug. treat heart disease. At 9:19 am, Strides Pharma Science quoted Rs 509.95, up Rs 11.30, or 2.27 per cent, on the BSE. Strides …
Strides Pharma trades 2% up after USFDA nod for drug to reduce heart issues Read More »